NSN 6505-01-653-1569, 6505016531569
DANTROLENE SODIUM FOR INJECTION

Federal Supply Classification: FSC 6505 - Drugs and Biologicals
National Item Identification Number: NIIN 016531569
Codification Country: United States
Item Name Code: INC 37569
Criticality: (X) This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application.
Hazardous Material Indicator Code: (P) There is no information in the HMIRS; however, the NSN is in an FSC in Table II of Federal Standard 313 and an MSDS may be required by the user. The requirement for an MSDS is dependent on a hazard determination of the supplier or the intended end use of the product.

Availability: Request Qualified Suppliers: Currently qualifying suppliers

Manufacture or supply this part?
Join our growing community of certified suppliers.

Let Us Know

CALL ABOUT NSN 6505-01-653-1569

Our client representatives are standing by to help fulfill your request.

+1-321-773-5710

REQUEST QUOTE for 6505-01-653-1569

Have a list that needs to be quoted? Upload it here.

Upload a List

DLMS^® Summary

National Stock Number 6505-01-653-1569

National Stock Number (NSN) 6505-01-653-1569, or NIIN 016531569, (dantrolene sodium for injection) was assigned March 14, 2016 in the Federal Logistics Information System (FLIS). This NIIN is Available for Manual Assignment. This NSN does not replace any other NSNs.

There are 3 manufacturer part numbers associated with this NSN. None of the associated part number(s) are considered obsolete. The manufacturer part numbers were originally supplied by 3 suppliers. Today, 3 suppliers are listed as Active suppliers for this NSN. Of the active suppliers, 3 suppliers are deemed design controlled or valid supply parts.

This part number is actively being procured by the US Government, with procurement history within the last 90 days. There have been 5 contracts issued for this part number, with 5 awards given. There is minimal competition for this NSN. The US Government has awarded contracts to 2 different suppliers. The last contract numbers awarded were: SPE2DP25P0317, SPE2DP25P0317, SPE2DP25P0317, SPE2DP25P0317, SPE2DP25P0317. The total value of the awarded contracts has been US$ 100,007.76.

There has been a moderate amount of demand for this national stock number. The demand for this NSN originated from less than 5 countries. Based on a planned procurement review by the Primary Inventory Control Activity (PICA) on Mar 24, 2016, this NSN's acquisition method was noted as: Acquire only from the prime contractor although the engineering data identifies the Commercial and Government Entity Code (CAGE) and part number of a source other than the prime contractor. This part is a commercial/non-developmental/off-the-shelf-item. Valid AMCs: 1, 2, 3, 4 and 5.

This NSN is assigned to Item Name Code (INC) 37569. This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. There is no information in the HMIRS; however, the NSN is in an FSC in Table II of Federal Standard 313 and an MSDS may be required by the user. The requirement for an MSDS is dependent on a hazard determination of the supplier or the intended end use of the product. NSN 6505016531569 does not contain precious metals.

This information was last updated on Jun 01, 2025.

Technical Characteristics

III PART NAME ASSIGNED BY CONTROLLING AGENCY: (CXCY) RYANODEX (DANTROLENE SODIUM) INJECTION 250MG
SPECIAL FEATURES: (FEAT) RYANODEX (DANTROLENE SODIUM) 250MG FOR RECONSTITUTION WITH 5ML STERILE WATER FOR INJECTION; (WITHOUT A BACTERIOSTATIC AGENT); 20ML VIAL; STORE UNRECONSTITUTED PRODUCT AT 20 TO 25 DEGREES CELSIUS (68-77 DEGREES FAHRENHEIT) - USP CONTROLLED ROOM TEMPERATURE; AVOID EXPOSURE TO LIGHT; MUST USE THE CONTENTS OF THE VIAL WITHIN 6 HOURS AFTER RECONSTITUTION; MANUFACTURER, EAGLE PHARMACEUTICALS DOES NOT HAVE A CAGE CODE
III PROTECTIVE STORAGE FEATURE: (AJCN) CONTROLLED ROOM TEMPERATURE
III USUAL DOSE: (CSLZ) 2.5 MG/KG ADMINISTERED INTRAVENOUSLY OVER A PERIOD OF AT LEAST 1 MINUTE, STARTING APPROXIMATELY 75 MINUTES PRIOR TO SURGERY
ACTIVE MEDICAMENT MEDICINAL STRENGTH: (AKJA) 250.0 MILLIGRAMS DANTROLENE SODIUM ACTIVE INGREDIENT
ADMINISTRATION: (CSGS) INTRAVENOUS
PART NAME ASSIGNED BY CONTROLLING AGENCY: (CXCY) RYANODEX (DANTROLENE SODIUM) INJECTION 250MG
PHYSICAL FORM: (AGXW) POWDER
PRIMARY CONTAINER CONTENT QUANTITY: (CRLK) 250.0 MILLIGRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: (CQCT) VIAL
PROTECTIVE STORAGE FEATURE: (AJCN) CONTROLLED ROOM TEMPERATURE
SPECIAL FEATURES: (FEAT) DANTROLENE SODIUM 250MG FOR RECONSTITUTION WITH 5ML STERILE WATER FOR INJECTION; (WITHOUT A BACTERIOSTATIC AGENT); STORE UNRECONSTITUTED PRODUCT AT 20 TO 25 DEGREES CELSIUS (68-77 DEGREES FAHRENHEIT) - USP CONTROLLED ROOM TEMPERATURE; AVOID EXPOSURE TO LIGHT; MUST USE THE CONTENTS OF THE VIAL WITHIN 6 HOURS AFTER RECONSTITUTION; MANUFACTURER, EAGLE PHARMACEUTICALS DOES NOT HAVE A CAGE CODE.
USUAL DOSE: (CSLZ) 2.5 MG/KG ADMINISTERED INTRAVENOUSLY OVER A PERIOD OF AT LEAST 1 MINUTE, STARTING APPROXIMATELY 75 MINUTES PRIOR TO SURGERY